Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06890208Recruiting

Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave

Role: collaborator

NCT04661462Unknown

Health After Covid-19 in Tyrol

Role: collaborator

NCT01146587Not ApplicableSuspended

Comparative Study of GangTrainer GT1, Lokomat and Conventional Physiotherapy

Role: collaborator

All 3 trials loaded